Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

ClinicalTrials.gov ID: NCT00058981

Public ClinicalTrials.gov record NCT00058981. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:10 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Investigate the Safety and Tolerability as Well as the Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in LADA Subjects

Study identification

NCT ID
NCT00058981
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
DeveloGen Israel, Ltd.
Industry
Enrollment
100 participants

Conditions and interventions

Interventions

  • DiaPep277 Drug

Drug

Eligibility (public fields only)

Age range
30 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2002
Primary completion
Feb 28, 2007
Completion
Apr 30, 2007
Last update posted
Mar 18, 2009

2002 – 2007

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
University of Alabama at Birmingham Endocrinology Department Birmingham Alabama 35294
University of Colorado Hospital Endocrinology Practice Aurora Colorado 80010
University of Kentucky Department of Internal Medicine Lexington Kentucky 40536
Washington University School of Medicine Endocrinology/Metabolic Dept St Louis Missouri 63110
North Shore Diabetes and Endocrine Associates New Hyde Park New York 11042
Diabetes & Glandular Disease Research Associates San Antonio Texas 78229-4801
DVA Puget Sound Health Care System Endocrinology (III) Department Seattle Washington 98108

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00058981, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 18, 2009 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00058981 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →